Efficacy and safety of selegiline for the treatment of Parkinson's disease: A systematic review and meta-analysis.

Wang, Ke; Liu, Ze-Hui; Li, Xin-Ya; Li, Yan-Fei; Li, Jia-Rui; Hui, Jiao-Jiao; Li, Jing-Xuan; Zhou, Jun-Wen; Yi, Zhan-Miao

Wang, Ke; Liu, Ze-Hui; Li, Xin-Ya; Li, Yan-Fei; Li, Jia-Rui; Hui, Jiao-Jiao; Li, Jing-Xuan; Zhou, Jun-Wen; Yi, Zhan-Miao.

Afiliación

Wang K; Department of Pharmacy, Peking University Third Hospital, Beijing, China.
Liu ZH; Department of Pharmacy, Xuanwu Hospital of Capital Medical University, Beijing, China.
Li XY; Department of Pharmacy, Peking University Third Hospital, Beijing, China.
Li YF; Department of Pharmacy, Aerospace Central Hospital, Beijing, China.
Li JR; Department of Pharmacy, Peking University Third Hospital, Beijing, China.
Hui JJ; Department of Pharmacy, Peking University Third Hospital, Beijing, China.
Li JX; Department of Pharmacy, Peking University Third Hospital, Beijing, China.
Zhou JW; Department of Pharmacy, Peking University Third Hospital, Beijing, China.
Yi ZM; Department of Pharmacy, The First People's Hospital of Xianyang, Shaanxi, China.

Front Aging Neurosci ; 15: 1134472, 2023.

Article en En | MEDLINE | ID: mdl-37113570

Palabras clave

Hamilton Depression Rating Scale; Parkinson's disease; Unified Parkinson's Disease Rating Scale; Webster Rating Scale; adverse events; selegiline

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Systematic_reviews Idioma: En Revista: Front Aging Neurosci Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google